Geode Capital Management’s OncoSec Medical Incorporated ONCS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,512
| Closed | -$27.1K | – | 4882 |
|
|
2023
Q1 | $27.1K | Sell |
10,512
-1,986
| -16% | -$3.94K | ﹤0.01% | 4648 |
|
|
2022
Q4 | $20K | Buy |
12,498
+35
| +0.3% | +$196 | ﹤0.01% | 4771 |
|
|
2022
Q3 | $133K | Buy |
12,463
+88
| +0.7% | +$1.32K | ﹤0.01% | 4424 |
|
|
2022
Q2 | $201K | Buy |
12,375
+35
| +0.3% | +$671 | ﹤0.01% | 4266 |
|
|
2022
Q1 | $312K | Buy |
12,340
+409
| +3% | +$8.63K | ﹤0.01% | 4166 |
|
|
2021
Q4 | $251K | Buy |
11,931
+794
| +7% | +$26.8K | ﹤0.01% | 4380 |
|
|
2021
Q3 | $521K | Buy |
11,137
+2,804
| +34% | +$142K | ﹤0.01% | 4013 |
|
|
2021
Q2 | $515K | Buy |
8,333
+1,909
| +30% | +$173K | ﹤0.01% | 3929 |
|
|
2021
Q1 | $674K | Buy |
6,424
+2,712
| +73% | +$371K | ﹤0.01% | 3706 |
|
|
2020
Q4 | $526K | Buy |
3,712
+1,420
| +62% | +$151K | ﹤0.01% | 3577 |
|
|
2020
Q3 | $170K | Hold |
2,292
| – | – | ﹤0.01% | 3769 |
|
|
2020
Q2 | $103K | Buy |
2,292
+334
| +17% | +$14.2K | ﹤0.01% | 3845 |
|
|
2020
Q1 | $54K | Hold |
1,958
| – | – | ﹤0.01% | 3912 |
|
|
2019
Q4 | $77K | Hold |
1,958
| – | – | ﹤0.01% | 4018 |
|
|
2019
Q3 | $84K | Hold |
1,958
| – | – | ﹤0.01% | 3983 |
|
|
2019
Q2 | $108K | Buy |
1,958
+191
| +11% | +$18.4K | ﹤0.01% | 3944 |
|
|
2019
Q1 | $216K | Hold |
1,767
| – | – | ﹤0.01% | 3716 |
|
|
2018
Q4 | $248K | Buy |
1,767
+743
| +73% | +$187K | ﹤0.01% | 3610 |
|
|
2018
Q3 | $315K | Buy |
1,024
+105
| +11% | +$32.3K | ﹤0.01% | 3611 |
|
|
2018
Q2 | $279K | Buy |
919
+286
| +45% | +$100K | ﹤0.01% | 3622 |
|
|
2018
Q1 | $261K | Buy |
633
+374
| +144% | +$153K | ﹤0.01% | 3609 |
|
|
2017
Q4 | $92K | Hold |
259
| – | – | ﹤0.01% | 3837 |
|
|
2017
Q3 | $54K | Hold |
259
| – | – | ﹤0.01% | 3927 |
|
|
2017
Q2 | $67K | Hold |
259
| – | – | ﹤0.01% | 3909 |
|
|
2017
Q1 | $72K | Hold |
259
| – | – | ﹤0.01% | 3885 |
|
|
2016
Q4 | $70K | Hold |
259
| – | – | ﹤0.01% | 3858 |
|
|
2016
Q3 | $97K | Hold |
259
| – | – | ﹤0.01% | 3810 |
|
|
2016
Q2 | $93K | Hold |
259
| – | – | ﹤0.01% | 3816 |
|
|
2016
Q1 | $145 | Hold |
259
| – | – | ﹤0.01% | 3726 |
|
|
2015
Q4 | $135K | Hold |
259
| – | – | ﹤0.01% | 3807 |
|
|
2015
Q3 | $293K | Buy |
+259
| New | +$340K | ﹤0.01% | 3505 |
|
Geode Capital Management's ONCS Position: Q2 2023 in Review
Geode Capital Management sold out of OncoSec Medical Incorporated (ONCS) in Q2 2023, closing a stake of 10,512 shares — an estimated $27.1K sold.
Geode Capital Management first reported a position in ONCS in Q3 2015 and held it in 31 quarters. The position peaked at $674K in Q1 2021. 0 funds tracked by Wall St. Rank hold ONCS as of Q2 2023.
- Geode Capital Management reported no remaining OncoSec Medical Incorporated position as of Q2 2023 after selling out during the quarter.
- Geode Capital Management sold 10,512 OncoSec Medical Incorporated shares in Q2 2023, an estimated $27.1K.
- Geode Capital Management first reported a position in OncoSec Medical Incorporated in Q3 2015 and held it in 31 quarters.
- Geode Capital Management's OncoSec Medical Incorporated position peaked at $674K in Q1 2021.
- 0 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2023.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.